Shares of DexCom, Inc. (DXCM), that makes continuous glucose monitoring systems have touched its 52 week high of $400.79 on Thursday. The stock is currently at 393.69, more than 7% up.
DexCom will be added to the S&P 500, effective Tuesday, May 12, replacing Allergan (AGN).
On May 4, the company said, its G6 Continuous Glucose Monitoring has been temporarily authorized by Health Canada to monitor patients during the COVID-19 pandemic.
For comments and feedback contact: editorial@rttnews.com
Business News
December 26, 2025 08:42 ET Third quarter economic growth data from some major economies including the U.S. were the main news in this holiday shortened week. GDP growth and industrial production data from the U.S. helped to boost morale, while the consumer confidence survey results were less upbeat. In Europe, the quarterly economic growth data from the U.K. drew attention, while the minutes of the Australian central bank’s latest policy session was in focus in Asia.